Xiaoyan Qiu

995 total citations
26 papers, 618 citations indexed

About

Xiaoyan Qiu is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Xiaoyan Qiu has authored 26 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Xiaoyan Qiu's work include Glycosylation and Glycoproteins Research (5 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Chemokine receptors and signaling (3 papers). Xiaoyan Qiu is often cited by papers focused on Glycosylation and Glycoproteins Research (5 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Chemokine receptors and signaling (3 papers). Xiaoyan Qiu collaborates with scholars based in China, United States and Ethiopia. Xiaoyan Qiu's co-authors include Dalong Ma, Shaojun Wen, Rui‐Ping Xiao, Xiaomei Guo, Yanhong Guo, Dongmei Yang, Qian Li, Kuang‐Hueih Chen, Jian Tang and Pengfei Li and has published in prestigious journals such as Nature Cell Biology, Cancer Research and Life Sciences.

In The Last Decade

Xiaoyan Qiu

26 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoyan Qiu China 11 399 126 109 85 63 26 618
Jun Dong China 15 328 0.8× 74 0.6× 38 0.3× 93 1.1× 51 0.8× 40 591
Wei Rao China 10 290 0.7× 50 0.4× 85 0.8× 113 1.3× 44 0.7× 25 555
Takashi Tasaki Japan 15 237 0.6× 137 1.1× 133 1.2× 60 0.7× 96 1.5× 53 678
Halliday Idikio Canada 15 232 0.6× 89 0.7× 91 0.8× 42 0.5× 60 1.0× 40 591
Mitsumi Arito Japan 14 284 0.7× 63 0.5× 120 1.1× 88 1.0× 63 1.0× 44 579
Lizhen Gui United States 8 330 0.8× 94 0.7× 56 0.5× 112 1.3× 69 1.1× 9 580
Presley L. Cannon United States 11 411 1.0× 140 1.1× 265 2.4× 124 1.5× 30 0.5× 13 828
Masaaki Awane Japan 12 395 1.0× 339 2.7× 77 0.7× 45 0.5× 45 0.7× 27 763
Eline Van Craeyveld Belgium 17 275 0.7× 39 0.3× 109 1.0× 83 1.0× 28 0.4× 28 728
Takahito Sugase Japan 10 157 0.4× 142 1.1× 62 0.6× 49 0.6× 135 2.1× 58 473

Countries citing papers authored by Xiaoyan Qiu

Since Specialization
Citations

This map shows the geographic impact of Xiaoyan Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyan Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyan Qiu more than expected).

Fields of papers citing papers by Xiaoyan Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyan Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyan Qiu. The network helps show where Xiaoyan Qiu may publish in the future.

Co-authorship network of co-authors of Xiaoyan Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyan Qiu. A scholar is included among the top collaborators of Xiaoyan Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyan Qiu. Xiaoyan Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Qianqian, Yifan Wang, Xiaofeng Liu, et al.. (2024). Hepatocyte-derived Igκ promotes HCC progression by stabilizing electron transfer flavoprotein subunit α to facilitate fatty acid β-oxidation. Journal of Experimental & Clinical Cancer Research. 43(1). 280–280. 5 indexed citations
3.
Wu, Jie, et al.. (2024). High Expression of Cancer-derived Immunoglobulin G is Associated with Poor Survival in Metastatic Clear Cell Renal Cell Carcinoma. European Urology Open Science. 61. 56–58. 1 indexed citations
4.
Zhu, Zhu, Pingzhang Wang, Xiaodong Jia, et al.. (2023). B-Cell Receptor Features and Database Establishment in Recovered COVID-19 Patients by Combining 5'-RACE with PacBio Sequencing. Frontiers in Bioscience-Landmark. 28(2). 40–40. 1 indexed citations
5.
Tang, Jingshu, Yang Liu, Jing Huang, et al.. (2023). A Self-Propagating c-Met–SOX2 Axis Drives Cancer-Derived IgG Signaling That Promotes Lung Cancer Cell Stemness. Cancer Research. 83(11). 1866–1882. 17 indexed citations
6.
Zhu, Zhu, Yanqun Wang, Pingzhang Wang, et al.. (2022). A new strategy: identification of specific antibodies for neutralizing epitope on SARS-CoV-2 S protein by LC-MS/MS combined with immune repertoire. Molecular Biomedicine. 3(1). 20–20. 2 indexed citations
7.
Chen, Yuxin, Lulu Han, Xiaoyan Qiu, et al.. (2022). Reassembling of albumin-bound paclitaxel mitigates myelosuppression and improves its antitumoral efficacy via neutrophil-mediated targeting drug delivery. Drug Delivery. 29(1). 728–742. 15 indexed citations
8.
Yao, Qingyu, et al.. (2022). An integrated PK/PD model investigating the impact of tumor size and systemic safety on animal survival in SW1990 pancreatic cancer xenograft. Acta Pharmacologica Sinica. 44(2). 465–474. 2 indexed citations
9.
Tian, Xinyu, Song Wang, Xinxin Chen, et al.. (2021). Low serum IgG4 level: a potential diagnostic biomarker for IgA nephropathy. Annals of Translational Medicine. 9(9). 781–781. 1 indexed citations
10.
Wang, Guohui, Jing You, Xiaohong Xu, et al.. (2021). High Expression of Cancer-IgG Is Associated With Poor Prognosis and Radioresistance via PI3K/AKT/DNA-PKcs Pathway Regulation in Lung Adenocarcinoma. Frontiers in Oncology. 11. 675397–675397. 10 indexed citations
11.
Cui, Ming, Lei You, Bang Zheng, et al.. (2020). High Expression of Cancer-Derived Glycosylated Immunoglobulin G Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma. Journal of Cancer. 11(8). 2213–2221. 23 indexed citations
12.
Qiu, Xiaoyan, et al.. (2019). SOCS1 and its Potential Clinical Role in Tumor. Pathology & Oncology Research. 25(4). 1295–1301. 28 indexed citations
13.
Qiu, Xiaoyan, et al.. (2017). Analysis of risk factors for lumbar puncture with abnormal results in febrile young babies. 24(6). 468–470. 1 indexed citations
14.
Wang, Jing, Guoying Zhang, Yingmei Zhang, et al.. (2014). CMTM1_v17 is a novel potential therapeutic target in breast cancer. Oncology Reports. 32(5). 1829–1836. 18 indexed citations
15.
16.
Qiu, Xiaoyan, et al.. (2011). Expression of matrix metalloproteinases and their inhibitors at the feto‐maternal interface in unruptured ectopic tubal pregnancy. Acta Obstetricia Et Gynecologica Scandinavica. 90(9). 966–971. 5 indexed citations
17.
Konoplev, Sergej, et al.. (2010). Clonal Relationship of Extranodal Marginal Zone Lymphomas of Mucosa-Associated Lymphoid Tissue Involving Different Sites. American Journal of Clinical Pathology. 134(1). 112–118. 21 indexed citations
18.
Yin, C. Cameron, Lynne V. Abruzzo, Xiaoyan Qiu, et al.. (2009). del(15q) is a recurrent minor-route cytogenetic abnormality in the clonal evolution of chronic myelogenous leukemia. Cancer Genetics and Cytogenetics. 192(1). 18–23. 5 indexed citations
19.
Wang, Yu, Xiaoyan Qiu, Xiaoning Mo, et al.. (2006). Characterization and Expression Profile of CMTM3/CKLFSF3. BMB Reports. 39(5). 537–545. 45 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Dong Breakdown of academic impact, for papers by Wei Rao Breakdown of academic impact, for papers by Takashi Tasaki Breakdown of academic impact, for papers by Halliday Idikio Breakdown of academic impact, for papers by Mitsumi Arito Breakdown of academic impact, for papers by Lizhen Gui Breakdown of academic impact, for papers by Presley L. Cannon Breakdown of academic impact, for papers by Masaaki Awane Breakdown of academic impact, for papers by Eline Van Craeyveld Breakdown of academic impact, for papers by Takahito Sugase
Rankless by CCL
2026